Urinary tract infections in special populations. diabetes, renal transplant, HIV infection, and spinal cord injury

Infectious Disease Clinics of North America

Volumn 28, Issue 1, 2014, Pages 91-104

  Nicolle, Lindsay E ^a  

^a HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Asymptomatic bacteriuria; Cystitis; Diabetes; HIV infection; Pyelonephritis; Renal transplant; Spinal cord injury; Urinary infection

Indexed keywords

ASYMPTOMATIC BACTERIURIA; CYSTITIS; DIABETES; HIV INFECTION; PYELONEPHRITIS; RENAL TRANSPLANT; SPINAL CORD INJURY; URINARY INFECTION;

ANTI-BACTERIAL AGENTS; DIABETES COMPLICATIONS; HIV INFECTIONS; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SPINAL CORD INJURIES; URINARY TRACT INFECTIONS;

EID: 84895076611     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2013.09.006     Document Type: Review

References (60)

1. Hoepelman A.I., Meiland R., Geerlings S.E. Pathogenesis and management of bacterial urinary tract infections in adult patients with diabetes mellitus. Int J Antimicrob Agents 2003, 22(Suppl 2):35-43.
2. Chen S.L., Jackson S.L., Boyko E.J. Diabetes mellitus and urinary tract infection: epidemiology, pathogenesis and proposed studies in animal models. JUrol 2009, 182:S51-S56.
3. Nicolle L.E. Urinary tract infection in diabetes. Curr Opin Infect Dis 2005, 18:49-53.
4. Gorter K.J., Hak E., Zuithoff P.A., et al. Risk of recurrent acute lower urinary tract infections and prescription patterns of antibiotics with and without diabetes in primary care. Fam Pract 2010, 27:379-385.
5. Geerlings S.E., Stolk R.P., Camps M.J., et al. Risk factors for symptomatic urinary tract infection in women with diabetes. Diabetes Care 2000, 23:1737-1741.
6. Zhanel G.G., Nicolle L.E., Harding G.K. Prevalence of asymptomatic bacteriuria and associated host factors in women with diabetes mellitus. Clin Infect Dis 1995, 21:316-322.
7. Abdul-Ghani M.A., Norton L., DeFronzo R.A. Efficacy and safety of SGLT2 inhibitors in the treatment of Type 2 diabetes mellitus. Curr Diab Rep 2012, 12:230-238.
8. Czaja C.A., Rutledge B.N., Cleary P.A., et al. Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort. JUrol 2009, 181:1129-1135.
9. Boyko E.J., Fihn S.D., Scholes D., et al. Diabetes and the risk of acute urinary tract infection among post-menopausal women. Diabetes Care 2002, 25:1778-1783.
10. Coelho R.F., Schneider-Montero E.D., Mesquita J.L., et al. Renal and perinephric abscesses: analysis of 65 cases. World J Surg 2007, 31:431-436.
11. Bjurlin M.A., Hurley S.D., Kim D.Y., et al. Clinical outcomes of nonoperative management in emphysematous urinary tract infections. Urology 2012, 79:1281-1285.
12. Thomas A.A., Lane B.R., Thomas A.Z., et al. Emphysematous cystitis: a review of 135 cases. BJU Int 2007, 100:17-20.
13. Nicolle L.E. Urinary tract infection. Crit Care Clin 2013, 29:699-715.
14. Kofterdis D.P., Papademitraki E., Mantadakis E., et al. Effect of diabetes mellitus and the clinical and microbiological features of hospitalized elderly patients with acute pyelonephritis. JAm Geriatr Soc 2009, 57:2125-2128.
15. Nicolle L.E. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am 2008, 35:1-12.
16. Durwood E.N. Complicated urinary tract infections. Urol Clin North Am 2008, 35:13-22.
17. Gupta K., Hooton T.M., Naber K.G., et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011, 52:e103-e120.
18. Pertel P.E., Haverstock D. Rick factors for a poor outcome after therapy for acute pyelonephritis. BJU Int 2006, 98:141-147.
19. Chiu P.-F., Huang C.-H., Liou H.-H., et al. Long term renal outcomes of episodic urinary tract infection in diabetic patients. JDiabet Complications 2013, 27:41-43.
20. Harding G.K., Zhanel G.G., Nicolle L.E., et al. Antimicrobial treatment in diabetic women with asymptomatic bacteriuria. NEngl J Med 2002, 347:1576-1583.
21. Nicolle L.E., Bradley S., Colgan R., et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005, 40:643-654.
22. Alangaden G.J. Urinary tract infections in renal transplant recipients. Curr Infect Dis Rep 2007, 9:475-479.
23. Saemann M., Hoel W.H. Urinary tract infection in renal transplant recipients. Eur J Clin Invest 2008, 38(S2):58-65.
24. Rice J.C., Safdar N. Urinary tract infections in solid organ transplant recipients. Am J Transplant 2009, 9(S4):S267-S272.
25. Sorto R., Irizar S.S., Delgadillo G., et al. Risk factors for urinary tract infections during the first year after kidney transplantation. Transplant Proc 2010, 42:280-281.
26. Papasotiriou M., Savvidaki E., Kalliakmani P., et al. Predisposing factors for the development of urinary tract infections in renal transplant recipients and the impact on the long-term graft function. Ren Fail 2011, 33:404-410.
27. Golebiewska J., Debska-Slizien A., Komarnicka J., et al. Urinary tract infections in renal transplant recipients. Transplant Proc 2011, 43:2985-2990.
28. El Amari E.B., Hadaya K., Buhler L., et al. Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. Nephrol Dial Transplant 2011, 26:4109-4114.
29. Green H., Rahaminov R., Goldberg E., et al. Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study. Eur J Clin Microbiol Infect Dis 2013, 32:127-131.
30. Fiorante S., Fernandez-Ruiz M., Lopez-Medrano F., et al. Acute graft pyelonephritis in renal transplant recipients: incidence, risk factors and long-term outcome. Nephrol Dial Transplant 2011, 26:1065-1073.
31. Parapiboon W., Ingsathit A., Disthabanchong S., et al. Impact of early ureteric stent removal and cost-benefit analysis in kidney transplant recipients: results of a randomized controlled study. Transplant Proc 2012, 44:737-739.
32. Kasiske B.L., Zeier M.G., Chapman J.R., et al. KD1G0 clinical practice for the care of kidney transplant recipients: a summary. Kidney Int 2010, 77:299-311.
33. Kasiske B.L., Vazquez M.A., Harmon W.E., et al. Recommendations for the outpatient surveillance of renal transplant recipients. JAm Soc Nephrol 2000, 11:S1-S86.
34. Shindel A.W., Akhavan A., Sharlip I.D. Urologic aspects of HIV infection. Med Clin North Am 2011, 95:129-151.
35. Evans J.K., McOwan A., Hillman R.J., et al. Incidence of symptomatic urinary tract infections in HIV seropositive patients and the use of cotrimoxazole as prophylaxis against Pneumocystits carinii pneumonia. Genitourin Med 1995, 71:120-122.
36. Flanigan T.P., Hogan J.W., Smith D., et al. Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection. Clin Infect Dis 1999, 29:608-612.
37. Park J.C., Buono D., Smith D.K., et al. Urinary tract infections in women with or at risk for human immunodeficiency virus infection. Am J Obstet Gynecol 2002, 187:581-588.
38. De Pinho A.M., Lopes G.S., Ramos-Filho C.F., et al. Urinary tract infection in men with AIDS. Genitourin Med 1994, 70:30-34.
39. Breyer B.N., Van den Eden S.K., Horberg M.A., et al. HIV status is an independent risk factor for reporting lower urinary tract symptoms. JUrol 2011, 185:1710-1715.
40. Asharam K., Bhimma R., Adhikari M. Human immunodeficiency virus and urinary tract infections in children. Ann Trop Paediatr 2003, 23:273-277.
41. Ojoo J., Paul J., Batchelor B., et al. Bacteriuria in a cohort of predominantly HIV-1 seropositive female commercial sex workers in Nairobi, Kenya. JInfect 1996, 33:33-37.
42. Awolude O.A., Adesina O.A., Oladokun A., et al. Asymptomatic bacteriuria among HIV positive pregnant women. Virulence 2010, 1:130-133.
43. Ezechi O.C., Gab-Okafor C.V., Oladele D.A., et al. Prevalence and risk factors of asymptomatic bacteriuria among pregnant Nigerians infected with HIV. JMatern Fetal Neonatal Med 2013, 26:402-406.
44. Hopelman A.I.M., van Buren M., van den Brock J., et al. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). AIDS 1992, 6:179-184.
45. De Gaetano Donati R., Tumbarcello M., Tacconelli E., et al. Impact of highly active antiretroviral therapy (HAART) on the incidence of bacterial infections in HIV-infected subjects. JChemother 2003, 15:60-65.
46. Samson G., Cardenas D.D. Neurogenic bladder in spinal cord injury. Phys Med Rehabil Clin N Am 2007, 18:255-274.
47. D'Hondt F., Everaert K. Urinary tract infections in patients with spinal cord-injuries. Curr Infect Dis Rep 2011, 13:544-551.
48. Hooton T.M., Bradley S.F., Cardenas D.D., et al. Diagnosis, prevention, and treatment of catheter associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010, 50:625-663.
49. Esclarin de Ruz A., Leoni E.G., Cabrera R.H. Epidemiology and risk factors for urinary tract infection in patients with spinal cord injury. JUrol 2000, 164:1285-1289.
50. Ronco E., Denys P., Bernede-Bauduin C., et al. Diagnostic criteria of urinary tract infection in male patients with spinal cord injury. Neurorehabil Neural Repair 2011, 25:351-358.
51. Massa L.M., Hoffman J.M., Cardenas D.D. Validity, accuracy and predictive value of urinary tract infection signs and symptoms in individuals with spinal cord injury on intermittent catheterization. JSpinal Cord Med 2009, 32:568-573.
52. Dow G., Rao P., Harding G., et al. Aprospective randomized trial of 3 or 14 days of ciprofloxacin treatment for acute urinary tract infection in patients with spinal cord injury. Clin Infect Dis 2004, 39:658-664.
53. Everaert K., Lumen N., Kerckhaert W., et al. Urinary tract infections in spinal cord injury: Prevention and treatment guidelines. Acta Clin Belg 2009, 64:335-340.
54. Opperman E.A. Cranberry is not effective for the prevention or treatment of urinary tract infections in individuals with spinal cord injury. Spinal Cord 2010, 48:451-456.
55. Cardenas D.D., Morre K.N., Dannels-McClure A., et al. Intermittent catheterization with a hydrophilic-coated catheter delays urinary tract infections in acute spinal cord injury: a prospective, randomized, multicenter trial. PM R 2011, 3:408-417.
56. Bermingham S.L., Hodgkinson S., Wright S., et al. Intermittent self catheterization with hydrophilic, gel reservoir, and non-coated catheters: a systematic review and cost effectiveness analysis. BMJ 2013, 346:e8639.
57. Cardenas D.D., Hoffman J.M., Kelly E., et al. Impact of a urinary tract infection educational program in persons with spinal cord injury. JSpinal Cord Med 2004, 27:47-54.
58. Salomon J., Schnitzler A., Ville Y., et al. Prevention of urinary tract infection in six spinal cord injured pregnant women who gave birth to seven children under a weekly oral cyclic antibiotic program. Int J Infect Dis 2009, 13:399-402.
59. Darouiche R.O., Hull R.A. Bacterial interference for prevention of urinary tract infection. Clin Infect Dis 2012, 55:1400-1407.
60. Lavado E.L., Cardoso J.R., Silva L.G., et al. Effectiveness of aerobic physical training for treatment of chronic asymptomatic bacteriuria in subjects with spinal cord injury: a randomized controlled trial. Clin Rehabil 2013, 27:142-149.